Literature DB >> 12217417

In vitro quantitative study of the degradation of endomorphins.

Csaba Tömböly1, Antal Péter, Géza Tóth.   

Abstract

The catabolism of the endomorphins was investigated in detail. The endomorphins were degraded relatively slowly in the rat brain homogenate (t1/2(endomorphin-1)=4.94 min; t1/2(endomorphin-2)=3.81 min). The inhibition of metalloproteases and aminopeptidases stabilised the endomorphins to the greatest extent. The digestion of endomorphins tritiated specifically on Tyr(1), Pro(2) or Phe(3) established also that only the aminopeptidase pathways were essential for inactivation of the endomorphins, and that the tetrapeptides were degraded by cleavage of the Pro(2)-Trp(3) or Pro(2)-Phe(3) bond. The end-products of the catabolism were amino acids; the fragments Tyr-Pro-OH and Pro-Trp-Phe-NH2 were present as intermediates. Metabolites produced by brain carboxypeptidases were not detected.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217417     DOI: 10.1016/s0196-9781(02)00100-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Gino Lucente; Federica Feliciani; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

2.  Biological active analogues of the opioid peptide biphalin: mixed α/β(3)-peptides.

Authors:  Adriano Mollica; Francesco Pinnen; Roberto Costante; Marcello Locatelli; Azzurra Stefanucci; Stefano Pieretti; Peg Davis; Josephine Lai; David Rankin; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2013-04-12       Impact factor: 7.446

3.  Novel cyclic biphalin analogue with improved antinociceptive properties.

Authors:  Adriano Mollica; Alfonso Carotenuto; Ettore Novellino; Antonio Limatola; Roberto Costante; Francesco Pinnen; Azzurra Stefanucci; Stefano Pieretti; Anna Borsodi; Reza Samavati; Ferenc Zador; Sándor Benyhe; Peg Davis; Frank Porreca; Victor J Hruby
Journal:  ACS Med Chem Lett       Date:  2014-07-14       Impact factor: 4.345

4.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

5.  The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analogues.

Authors:  Adriano Mollica; Francesco Pinnen; Azzurra Stefanucci; Federica Feliciani; Cristina Campestre; Luisa Mannina; Anatoly P Sobolev; Gino Lucente; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2012-03-22       Impact factor: 7.446

6.  Kinetic studies of novel inhibitors of endomorphin degrading enzymes.

Authors:  Renata Perlikowska; Jakub Fichna; Jean Claude do-Rego; Katarzyna Gach; Anna Janecka
Journal:  Med Chem Res       Date:  2011-05-20       Impact factor: 1.965

7.  The spinal antinociceptive effects of endomorphins in rats: behavioral and G protein functional studies.

Authors:  Hong Xie; James H Woods; John R Traynor; Mei-Chuan Ko
Journal:  Anesth Analg       Date:  2008-06       Impact factor: 5.108

8.  The effects of endomorphins on striatal [3H]GABA release induced by electrical stimulation: an in vitro superfusion study in rats.

Authors:  Zsolt Bagosi; Miklós Jászberényi; Gyula Telegdy
Journal:  Neurochem Res       Date:  2008-10-08       Impact factor: 3.996

9.  Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner.

Authors:  Heather L Scanlin; Elizabeth A Carroll; Victoria K Jenkins; Agnieszka Balkowiec
Journal:  Eur J Neurosci       Date:  2008-05-29       Impact factor: 3.386

10.  Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.

Authors:  Yasuko Koda; Mark Del Borgo; Susanne T Wessling; Lawrence H Lazarus; Yoshio Okada; Istvan Toth; Joanne T Blanchfield
Journal:  Bioorg Med Chem       Date:  2008-04-15       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.